Connection
Robert Page to Ventricular Function, Left
This is a "connection" page, showing publications Robert Page has written about Ventricular Function, Left.
|
|
Connection Strength |
|
 |
|
 |
|
0.231 |
|
|
|
-
Schoenborn EM, Skersick PT, Thrasher CM, Page RL. Expanded use of sodium-glucose cotransporter 2 inhibitors: Evidence beyond heart failure with reduced ejection fraction. Pharmacotherapy. 2023 09; 43(9):950-962.
Score: 0.163
-
Joglar JA, Acusta AP, Shusterman NH, Ramaswamy K, Kowal RC, Barbera SJ, Hamdan MH, Page RL. Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. Am Heart J. 2001 Sep; 142(3):498-501.
Score: 0.036
-
Horton RP, Canby RC, Rom?n CA, Hull ML, Kaye SA, Jessen ME, Page RL. Determinants of nonthoracotomy biphasic defibrillation. Pacing Clin Electrophysiol. 1997 Jan; 20(1 Pt 1):60-4.
Score: 0.026
-
Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol. 1997 May; 29(6):1206-13.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|